Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Taryn Leroy

Orthopaedic Surgery of the Spine Boston, MA Medical Doctor

NPI 1538690375 CMS profile 3569489

125 Parker Hill Avenue, Converse 4, Boston, MA 02120

Open in the dashboard

General payments

$35,973

221 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Taryn Leroy of Boston, MA is reported in the CMS Open Payments database as having received $35,973 across 221 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,992 19
2024 General $14,720 68
2023 General $8,373 73
2022 General $4,863 43
2021 General $1,190 8
2020 General $327 2
2019 General $508 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Taryn Leroy
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Taryn Leroy were reported at $5,992. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Taryn Leroy Orthopaedic Surgery of the Spine median Middle half National median
2019 $508 $2,106 $337–$18,608 $163
2020 $327 $1,213 $156–$15,082 $114
2021 $1,190 $1,834 $271–$15,617 $132
2022 $4,863 $2,015 $320–$17,036 $149
2023 $8,373 $1,925 $336–$14,599 $160
2024 $14,720 $2,110 $341–$12,483 $164
2025 $5,992 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Spineart USA Inc $10,018 26 payments
  2. DePuy Synthes Products, Inc. $5,482 6 payments
  3. Medtronic, Inc. $5,121 43 payments
  4. Stryker Corporation $3,154 38 payments
  5. Alphatec Spine, Inc $2,756 24 payments
  6. Globus Medical, Inc. $1,959 20 payments
  7. Smaio SA $1,445 7 payments
  8. Medical Device Business Services, Inc. $1,213 8 payments
  9. Smaio USA Corporation $1,048 2 payments
  10. Spineart SA $730 6 payments
  11. Other $3,049 41 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $14,860 41 payments
  2. Food and Beverage $13,619 173 payments
  3. Consulting Fee $5,348 2 payments
  4. Grant $1,322 1 payment
  5. Education $824 4 payments
Products named General payments · program years 2019–2025
  1. CD HORIZON SPINAL SYSTEM $2,384 28 payments
  2. Other - Miscellaneous $2,305 15 payments
  3. EVEREST SPINAL SYSTEM $2,252 16 payments
  4. UNID_PASS $1,936 7 payments
  5. PERLA TL $1,257 10 payments
  6. Baguera-C $730 6 payments
  7. RISE-L . RISE-L A/L $702 6 payments
  8. ExcelsiusGPS Robotic Navigation System $649 6 payments
  9. EXPEDIUM $500 5 payments
  10. CAPRI CORPECTOMY CAGE SYSTEM $469 5 payments
  11. Other $6,180 89 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

60

Median for Orthopedic Surgery: 203

Drug cost

$289

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 47 $241
Methocarbamol Generic 13 $47

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$97,264

Medicare's payments for the services billed

Medicare patients

147

Average age 74

Services billed

406

88 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 39%
Diabetes 29%
Osteoporosis 28%
Chronic kidney disease 24%
Ischemic heart disease 23%
Cancer 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

221 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record